DETAILED CORRESPONDENCE
This Office action is in response to the RCE received April 9, 2026.
The rejection under 35 U.S.C. 103 as obvious over WANG et al (EP-2711776 A1) is withdrawn in view of the comparative evidence of record wherein the inventive composition having the nitrogen-containing compound (B) demonstrates unexpected results with respect to improved defect reduction rates as seen in Table 3 of the specification.
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention.
(a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention.
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows:
1. Determining the scope and contents of the prior art.
2. Ascertaining the differences between the prior art and the claims at issue.
3. Resolving the level of ordinary skill in the pertinent art.
4. Considering objective evidence present in the application indicating obviousness or nonobviousness.
Claim(s) 19, 22, and 28 are rejected under 35 U.S.C. 102(a) (1) as being anticipated by YAMAMOTO et al (2017/0219927 A1).
The claimed invention recites the following:
PNG
media_image1.png
418
680
media_image1.png
Greyscale
PNG
media_image2.png
204
632
media_image2.png
Greyscale
YAMAMOTO et al disclose a treating composition comprising an anionic surfactant having a sulfo group meeting the claimed sulfonic acid formula of (a-1), see Tables 1, 2 and 3 Examples A01-A03, B01-B04 and C01-C15 on pages 7-9. with Table 1 attached for reference.
PNG
media_image3.png
242
590
media_image3.png
Greyscale
Example A01 discloses a hexadecyl sulfonic acid and i-butylamine meeting the composition in method claim 23.
Claim 19 for the content is met by the disclosure in Table 1.
Claims 22 and 23 are met at para. [0145], treatment composition is dissolved in water as reported in para. [0012]
Claims 28 is met by the disclosure in para. [00139] and [0140] wherein the treatment composition is added and then dried.
No claims are allowed.
Claim(s) 19-23, and 27-32 are rejected under 35 U.S.C. 103 as being unpatentable over YAMAMOTO et al (2017/0219927 A1).
The claimed invention is recited above and is included by reference.
YAMAMOTO et al has been discussed above for the composition being anticipated by the examples in Table 1.
Claim 20 to the surfactant is disclosed in para. [0119] where the surfactants can be used I in a combination of two or more.
Claim 21 is to the additive, which is not disclosed in a working example, however YAMAMOTO et al teaches its addition in para. [0123] to [0127], such as acid or base, germicide, antibacterial agent, a preservative, anti-mold agent, etc.
Claim 29- 31 to the process the resist pattern formed as a mask is supported in para. [0001] wherein the resist pattern is used in semiconductor production.
Claim 32 recites the content of the nitrogen-containing compound in 0.01 to 20 mass % based on the total mass of the replacement liquid, which is met
Claims 24-28 are met by the cleaning step in para. [0045] with water after the treating solution for lithography.
Claims 29-31 are conventional processing steps to use the resulting resist pattern, either in mask making or printed wiring boards, para. [0004].
Claim 32 recites the contents of the nitrogen-containing compound, the solvent and the content of polymer (D). each of content of those ingredients is found in paras. [0115], and Example A02 wherein the balance of solvent is 99.9% (surfactant 500 ppm and amine 500 ppm (0.05% + 0.05% = 0.1%)
It would have been prima facie obvious to one of ordinary skill in the art of photosensitive compositions to add a base such as an amine to the rinse solution of YAMAMOTO et al in the contents recited above after the formation of resist patterns with the reasonable expectation of no pattern collapse, no surface defects and surface roughness.
Claims 17, 18, 24-26 and 33 are objected to as being dependent upon a rejected base claim but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims.
None of the prior art references of record disclose the claimed limitations found in claims 24-26 for the application of a cleaning liquid, no drying of the resist patterns and removal of the replacement liquid is performed by applying a cleaning liquid to between the resist patterns.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOHN S. CHU whose telephone number is (571)272-1329. The examiner can normally be reached on M-F, IFP-Flex.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Keith Hendricks, can be reached at telephone number 571-272-1401. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of an application may be obtained from Patent Center. Status information for published applications may be obtained from Patent Center. Status information for unpublished applications is available through Patent Center to authorized users only. Should you have questions about access to the USPTO patent electronic filing system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free).
Examiner interviews are available via a variety of formats. See MPEP § 713.01. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) Form at https://www.uspto.gov/InterviewPractice.
/John S. Chu/ Primary Examiner, Art Unit 1737
J. Chu
September 21, 2026